In an animal study, promoter DNA methylation of the glucokinase gene (Gck) decreased the expression of protein level and kinase activity in the rat liver, thereby increasing the risk of hyperglycemia and fatty liver [77]. The gene discussed is GCK; the disease is Hepatic steatosis.